Prelude Capital Management’s Acacia Research ACTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,000
Closed -$51K 1754
2021
Q4
$51K Buy
+10,000
New +$54K ﹤0.01% 1779
2021
Q2
Sell
-191,500
Closed -$1.27M 1620
2021
Q1
$1.27M Buy
+191,500
New +$1.21M 0.03% 517
2016
Q4
Sell
-22,369
Closed -$146K 1511
2016
Q3
$146K Buy
22,369
+8,731
+64% +$50.3K 0.02% 666
2016
Q2
$60K Buy
+13,638
New +$62.7K 0.01% 934
2014
Q1
Sell
-8,000
Closed -$116K 1824
2013
Q4
$116K Sell
8,000
-2,150
-21% -$34K 0.02% 809
2013
Q3
$234K Buy
+10,150
New +$232K 0.04% 492

Other funds holding ACTG

Prelude Capital Management's ACTG Position: Q1 2022 in Review

Prelude Capital Management sold out of Acacia Research (ACTG) in Q1 2022, closing a stake of 10,000 shares — an estimated $51K sold.

Prelude Capital Management first reported a position in ACTG in Q3 2013 and held it in 6 quarters. The position peaked at $1.27M in Q1 2021. 96 funds tracked by Wall St. Rank hold ACTG as of Q1 2022.

  • Prelude Capital Management reported no remaining Acacia Research position as of Q1 2022 after selling out during the quarter.
  • Prelude Capital Management sold 10,000 Acacia Research shares in Q1 2022, an estimated $51K.
  • Prelude Capital Management first reported a position in Acacia Research in Q3 2013 and held it in 6 quarters.
  • Prelude Capital Management's Acacia Research position peaked at $1.27M in Q1 2021.
  • 96 funds tracked by Wall St. Rank held Acacia Research as of Q1 2022.

Based on Prelude Capital Management's 13F filing for Q1 2022, filed 16 May 2022.